AEV 4.17% 1.2¢ avenira limited

Ann: Annual Report to shareholders, page-20

  1. 3,262 Posts.
    lightbulb Created with Sketch. 549
    further to this my opinion is that ihp is close to commercialisation.

    if it wasn't then management (also the purchaser) would be pointing out all the future cost that are associated with this interest.

    as it is the company hasn't provided a status update on ihp since they stated in April that they were looking for partners for a commercial plant.

    the lack of information given to shareholders noting sh are to vote on the sale of the novaphos asset, to me is a firm indication that ihp is commercial.

    management lack of transparency or any ethics on this is a total farce.
 
watchlist Created with Sketch. Add AEV (ASX) to my watchlist
(20min delay)
Last
1.2¢
Change
-0.001(4.17%)
Mkt cap ! $32.44M
Open High Low Value Volume
1.2¢ 1.2¢ 1.2¢ $3.567K 297.6K

Buyers (Bids)

No. Vol. Price($)
8 2973090 1.1¢
 

Sellers (Offers)

Price($) Vol. No.
1.2¢ 1000545 2
View Market Depth
Last trade - 14.31pm 06/09/2024 (20 minute delay) ?
AEV (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.